Singapore markets closed
Straits Times Index
3,314.14 +8.12 (+0.25%) S&P 500
5,462.80 -1.82 (-0.03%) Dow
39,222.79 +72.46 (+0.19%) Nasdaq
17,655.60 -33.75 (-0.19%) Bitcoin USD
61,343.28 -2,919.17 (-4.54%) CMC Crypto 200
1,259.34 -50.38 (-3.85%)
MRNA Jun 2025 60.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:09AM EDT. Market open.
Loading interactive chart…
- Simply Wall St.
Insiders At Moderna Sold US$3.3m In Stock, Alluding To Potential Weakness
In the last year, many Moderna, Inc. ( NASDAQ:MRNA ) insiders sold a substantial stake in the company which may have...
- Benzinga
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its blockbuster cancer drug Imfinzi combined with chemotherapy being used as a treatment forpatients suffering from specific type of endometrial cancer. Its pharma peer, BioNTech SE (NASDAQ: BNTX) wasn’t as lucky as also on Monday, the FDA put its experimental cancer drug study on partial clinical hold. Combining Immunotherapy And Chemotherapy Is Emerging As A New Standard In Ca
- Zacks
Moderna (MRNA) Stock Declines While Market Improves: Some Information for Investors
Moderna (MRNA) concluded the recent trading session at $137.90, signifying a -1.52% move from its prior day's close.
© 2024 Yahoo. All rights reserved.